Figure 4.
Percentage of patients in each APAPpl:APAPt group with (A) no liver injury (serum aminotransferase concentrations <50 IU l−1), (B) acute liver injury, (C) hepatotoxicity and (D) coagulopathy
Percentage of patients in each APAPpl:APAPt group with (A) no liver injury (serum aminotransferase concentrations <50 IU l−1), (B) acute liver injury, (C) hepatotoxicity and (D) coagulopathy